Clinical Data Scientist at Pharma and CROs: H-1B Sponsorship and STEM OPT Paths

Pharma giants and CROs sponsor H-1B and support STEM OPT for clinical data scientists — here is how to find those roles and land them.

You spent years building skills in SAS, R, Python, and clinical trial methodology. You understand CDISC standards, you know the difference between SDTM and ADaM datasets, and you can talk fluently about protocol deviations and data cleaning. Now you are about to graduate — or you are already on OPT — and you need a US employer who will sponsor a visa. The job boards show plenty of openings at Pfizer, ICON, IQVIA, and Parexel, but you are not sure which ones will actually move forward with an international candidate, and you are not sure whether your degree qualifies for STEM OPT extension.

The good news is that pharma and clinical research organizations (CROs) are among the most visa-friendly employers in the US economy. They have dedicated immigration teams, they understand the H-1B process, and they recruit internationally because the domestic pipeline for clinical data talent is thin relative to demand. The challenge is knowing exactly where to look, how to position yourself, and how to avoid wasting time on roles or employers that will stall at the sponsorship conversation.

The clinical data science landscape in pharma and CROs

Pharma and CRO data roles sit across a spectrum from pure data management to statistical programming to analytical data science. The titles matter for visa purposes because they affect the specialty-occupation argument USCIS evaluates.

The "specialty occupation" determination under 8 CFR 214.2(h)(4) requires that the position normally requires a bachelor's degree or higher in a specific field. All of the roles above clear that bar when positioned correctly in the petition. The H-1B Modernization Rule, effective January 17, 2025, codified deference to prior approvals, which matters because these employers have approved H-1Bs for these roles before — that track record works in your favor.

STEM OPT eligibility for clinical data scientists

Your OPT authorization comes from your student status. Whether you get the 24-month STEM extension depends on your degree's CIP code, not on what your employer calls your job.

Degrees that reliably appear on the DHS STEM Designated Degree Program List:

• Biostatistics (CIP 26.1102)
• Bioinformatics (CIP 26.1103)
• Data Science (CIP 30.7001)
• Statistics (CIP 27.0501)
• Computational Biology (CIP 26.1104)
• Health/Medical Informatics (CIP 51.0710)
• Public Health with quantitative concentration (some CIP codes qualify — check with your DSO)

Degrees that sometimes do NOT qualify:

• General public health (MPH) without a qualifying quantitative track
• Clinical research management programs at some schools
• Health administration (MHA)

What to do: Before accepting an offer, confirm your CIP code with your Designated School Official. If your degree qualifies, your employer must sign a Form I-983 Training Plan for STEM OPT Students, which the employer submits as part of the STEM extension. For a detailed walkthrough of the I-983, see our STEM OPT employer I-983 training plan guide.

The 90-day unemployment limit still applies during both initial 12-month OPT and the STEM extension. If you are between roles, that clock is running. Have your I-983 filed before day one at the new employer — late filing is the most common compliance mistake.

H-1B sponsorship at pharma companies

Large pharmaceutical companies operate immigration programs that file dozens to hundreds of H-1B petitions per year. Their legal teams have seen every RFE scenario and have established templates for clinical data and statistics roles.

Employers with strong track records in this space include Pfizer, Johnson & Johnson, Merck, Eli Lilly, AbbVie, Bristol Myers Squibb, Roche/Genentech, Novartis, AstraZeneca, and Sanofi. Mid-size companies like Biogen, Regeneron, Alexion, and Seagen (now part of Pfizer) also sponsor regularly. You can verify current H-1B filing activity for any employer by searching the USCIS H-1B Employer Data Hub at uscis.gov — it shows approvals and denials by employer, fiscal year, and initial/continuing distinction.

What to look for in a pharma role:

1. Confirm that the role itself exists as a full-time direct hire. Some pharma companies hire clinical data scientists through staffing agencies or CROs as vendors. Staffing agency H-1B sponsorship is a different calculus — review our notes on in-house vs staffing agency H-1B sponsorship before proceeding.
2. Ask the recruiter directly, early. You do not need to wait until an offer to ask whether the company sponsors H-1B. A plain question — "Does this role support H-1B sponsorship for candidates on OPT?" — is professional and expected. If the recruiter goes vague, treat that as a yellow flag.
3. Understand the LCA wage level. The Department of Labor's prevailing wage system sets H-1B salary floors at four levels (I–IV). Clinical data scientists at large pharma are typically filed at Level II or III, which aligns with market salaries. A company that wants to file at Level I for an MS-level role with 2+ years of clinical trial experience should raise questions.

H-1B sponsorship at CROs

Contract Research Organizations run clinical trials for pharma clients. The largest CROs — ICON, IQVIA, Syneos Health, Parexel, Labcorp Drug Development, and Medpace — all have substantial H-1B sponsorship programs. ICON plc, for example, operates globally and recruits internationally as a matter of course.

CRO roles differ from pharma in a few ways that affect your visa and career:

• Project-based work: You are staffed to client trials. When a trial ends, you move to the next one. USCIS approved the original petition for clinical data work in general, not for a specific trial — this is generally fine and well-understood.
• Travel requirements: Some CRO data roles require periodic on-site visits to investigator sites. Your H-1B LCA lists a primary worksite and you can work at client sites within the same Metropolitan Statistical Area. For remote or multi-site projects, the CRO's immigration team handles the LCA coverage — just flag travel expectations when reviewing the offer.
• Career path to pharma: Many international candidates start at a CRO to gain trial experience and then transfer to pharma after getting their green card process started. The transfer is straightforward because you are already cap-counted. See our guide on pharmaceutical industry visa sponsorship for a broader view of the career and visa arc.

For a comparison of how biostatistician roles at pharma and CROs are treated from a visa standpoint, our biostatistician H-1B sponsorship guide covers that sister role in detail.

Step-by-step: OPT to H-1B timeline for a clinical data scientist

Here is a realistic timeline for an international student starting a clinical data science role on OPT and transitioning to H-1B:

1. Month 0 (graduation or authorization start): 12-month OPT begins. Job search active. If your degree is STEM-eligible, you have up to 36 months total OPT runway (12 initial + 24 STEM).
2. Month 1-3: Accept offer. Submit I-983 Training Plan before or on day one. Confirm STEM OPT extension eligibility with DSO.
3. Month 5-8: H-1B lottery registration opens in March for the following October 1 start. Your employer's immigration attorney registers you. No filing fee at this stage.
4. Month 8-9 (if selected): Employer files I-129 petition between April 1 and June 30. Use premium processing ($2,965 as of March 2026) to get adjudication within 15 business days.
5. Month 12 (October 1): H-1B status begins if selected and approved. Your OPT ends but you are now in H-1B status.
6. If not selected in year 1: Continue on STEM OPT (24 more months). Re-enter lottery next March. You have two more lottery chances before STEM OPT exhausts.
7. Month 36 (latest STEM OPT end): If still not selected after three lottery attempts, evaluate alternatives — cap-exempt employers, O-1, EB-2 NIW self-petition, or countries with H-1B1 equivalent treaties.

Cap-exempt bridge strategy: If the lottery odds concern you, consider an academic medical center, NIH-funded research institute, or nonprofit clinical research organization as a first employer. These are cap-exempt under INA 214(g)(5), meaning you bypass the lottery entirely. After two to three years in a cap-exempt role building clinical trial experience, you can transfer to pharma or a CRO as a cap-exempt transfer (because you are already cap-counted).

Green card paths for clinical data scientists

H-1B gets you in the door. Green card is the long game.

PERM (EB-2 or EB-3): Most pharma and CRO companies start PERM labor certification after one to two years. PERM requires the employer to conduct a supervised recruitment process demonstrating no qualified US worker is available. For clinical data science roles, PERM generally proceeds smoothly when the job duties and requirements are specific and legitimate. After PERM approval, the employer files I-140 Immigrant Petition. For Indian and Chinese nationals, EB-2 and EB-3 backlogs mean years of waiting after I-140 approval — this is the priority date system managed via the Visa Bulletin.

EB-2 NIW (National Interest Waiver): If you have a strong publication record, a PhD, and documented contributions to clinical research methodology, you can self-petition for an EB-2 NIW without PERM or employer sponsorship. NIW requires demonstrating substantial merit, national importance, and that the US benefits from waiving normal job-offer requirements. Clinical researchers with peer-reviewed publications and demonstrable impact on FDA-regulated trial methodology have won NIW approvals. See our EB-2 NIW self-petition guide for the full framework.

O-1A: For clinical data scientists with exceptional ability — multiple publications, conference presentations, significant grant funding, or leadership in professional organizations (ASA, DIA, SCDM) — the O-1A nonimmigrant visa is a lottery-free path that can run parallel to a PERM-based green card process.

EB-1C: If you reach a senior management or executive role within a multinational pharma company, EB-1C (multinational executive or manager) is a faster green card path that skips PERM entirely.

Common mistakes

Accepting a role through a staffing agency thinking the agency will sponsor H-1B. Some staffing agencies do file H-1Bs, but the sponsoring employer of record is the agency, not the pharma end client. This matters because if the agency loses the client contract, your H-1B may be at risk. Ask specifically who will sign the I-129 and LCA.

Not filing the I-983 before day one. STEM OPT compliance requires the training plan to be in place before employment starts. A late I-983 can result in an OPT compliance violation and jeopardize the STEM extension.

Assuming your MPH degree qualifies for STEM OPT without checking the CIP code. Many MPH programs do not carry a STEM-eligible CIP code. Verify with your DSO, not with the employer, and not with assumptions.

Waiting until OPT month 11 to ask about H-1B lottery registration. H-1B lottery registration for October 1 start dates opens in March. If your OPT starts after April and you miss that March window, you have to wait a full additional year. Know the calendar before you accept an offer.

Overlooking cap-exempt employers. University hospitals and academic research centers conducting clinical trials are cap-exempt and hire clinical data scientists regularly. Many international candidates ignore these employers because the salary appears lower, but the visa certainty is significantly higher.

Choosing a CRO role without understanding the employment model. Make sure the CRO is your direct employer filing the H-1B — not a vendor arrangement where the CRO is supplying you to a pharma company that would theoretically be your real worksite. Employer-employee relationship under USCIS standards requires that the petitioner has the right to control your work.

Frequently asked questions

Do large pharma companies and CROs sponsor H-1B for clinical data scientists?

Yes — large pharmaceutical companies and major CROs are among the most consistent H-1B sponsors in the life sciences. They file petitions year-round for clinical data scientists, biostatisticians, and clinical data managers. Their immigration infrastructure is well-established and they understand the process thoroughly.

Is clinical data science a STEM OPT-eligible field?

It depends on your degree, not your job title. A master's or PhD in biostatistics, bioinformatics, data science, statistics, or a qualifying public health concentration will appear on the DHS STEM Designated Degree Program List. Confirm your specific CIP code with your DSO before accepting a role and filing the I-983 training plan.

What is the difference between a clinical data scientist and a biostatistician at a pharma company?

Clinical data scientists focus on data collection integrity, EDC systems, data cleaning, CDISC standards, and analytical readiness for regulatory submission. Biostatisticians design the statistical analysis plan, write the protocol analysis sections, and generate the primary efficacy tables. Both roles are filled by international candidates and both qualify as H-1B specialty occupations under USCIS guidelines.

Which CROs are known for sponsoring H-1B visas for data roles?

ICON plc, IQVIA, Syneos Health, PRA Health Sciences (now part of ICON), Parexel, and Labcorp Drug Development all have established H-1B sponsorship programs for clinical data and statistical roles. Confirm current sponsorship by searching the USCIS H-1B employer data tool at uscis.gov before applying.

Can a cap-exempt university hospital or academic medical center help me bridge to pharma?

Yes — academic medical centers conducting NIH-funded clinical trials are cap-exempt H-1B employers. Working there lets you gain trial experience without depending on the lottery. Once you have several years of trial experience, transferring to a pharma or CRO role is straightforward because you are already cap-counted and the new employer files a cap-exempt transfer.

Clinical data science is one of the more navigable paths for international candidates in life sciences. The roles are well-suited to the H-1B specialty-occupation standard, the major employers have real immigration infrastructure, and the STEM OPT runway gives you multiple lottery chances. The key is treating the visa strategy as part of your job search from the start — not an afterthought once you have an offer.

If you want a second set of eyes on your situation — whether that is evaluating a specific employer, reviewing your STEM OPT eligibility, or planning a timeline around the H-1B lottery — F1Jobs works with clinical data scientists and life sciences candidates every month.